Kunihara, Takahiro
Tohmori, Hidetoshi
Tsukamoto, Manabu http://orcid.org/0000-0003-4577-5072
Kobayashi, Masashi
Okumura, Toshiya
Teramoto, Hidefumi
Hamasaki, Takahiko
Yamasaki, Takuma
Nakagawa, Tsuyoshi
Okimoto, Nobukazu http://orcid.org/0000-0001-5323-0350
Fujiwara, Saeko http://orcid.org/0000-0002-0114-5266
Article History
Received: 16 November 2022
Accepted: 21 March 2023
First Online: 31 March 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Formal consent is not required for this type of study.
: N. Okimoto received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd. and Teijin Pharma Ltd. N. O received payments for lectures, including speakers’ bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd.; Amgen K. K.; Chugai Pharmaceutical Co.; Daiichi-Sankyo Co. Ltd.; Eli Lilly Japan.; and Teijin Pharma Ltd. S. Fujiwara received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd. T. Kunihara, H. Tohmori, M. Tsukamoto, M. Kobayashi, T. Okumura, H. Teramoto, T. Hamasaki, T. Yamasaki, and T. Nakagawa declare that they have no conflict of interest.